Agency Links:
Home
Contact Us
Compliments & Complaints
Help
Site Map
Patient/Public Info
|
Regional Services
|
Health Professionals Info
|
About BCCA
|
Research
|
Donating
BC Cancer Agency
>>
Health Professionals Info
>>
Cancer Management Guidelines
>>
Lung (including Mesothelioma & Thymoma)
>>
6. Management
>>
6.1 Non-Small Cell Lung Cancer (NSCLC)
6. Management
6.1 Non-Small Cell Lung Cancer (NSCLC)
01) Resectable NSCLC
02) Surgical Treatment of Stage I-IIIA
03) Adjuvant Radical Radiotherapy Following Surgical Resection
04) Post-operative Adjuvant Chemotherapy for Resected NSCLC
05) Radical Radiotherapy for Potentially Resectable but Inoperable T1, T2, N0, M0
06) Combined Modality Therapy for Unresectable Stage III
07) Combined Modality Therapy for Potentially Resectable Stage III
08) Patient Selection for Combined Modality Therapy
09) Chemotherapy in Combined Modality Regimens
10) Thoracic Radiotherapy In Combined Modality Therapy
11) Thoracic Radiotherapy Alone in Stage III
12) Advanced NSCLC Treated with Palliative Intent
13) Palliative Radiotherapy for Locally Advanced and Metastatic NSCLC
14) Palliative Chemotherapy of Advanced NSCLC
15) Palliative Second-line Chemotherapy for Advanced NSCLC
16) Endobronchial Therapy
Pre-operative Radical Radiotherapy
6.1 Non-Small Cell Lung Cancer (NSCLC)
Print this Page
Updated Feb. 2008
Please see the content listing on the left-hand side of your screen: from 01 to 16.